EA016814B1 - Замещенные изотопами ингибиторы протонного насоса - Google Patents
Замещенные изотопами ингибиторы протонного насоса Download PDFInfo
- Publication number
- EA016814B1 EA016814B1 EA200800203A EA200800203A EA016814B1 EA 016814 B1 EA016814 B1 EA 016814B1 EA 200800203 A EA200800203 A EA 200800203A EA 200800203 A EA200800203 A EA 200800203A EA 016814 B1 EA016814 B1 EA 016814B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methoxy
- hydrogen
- compounds
- methyl
- difluoromethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106868 | 2005-07-26 | ||
| PCT/EP2006/064666 WO2007012650A1 (fr) | 2005-07-26 | 2006-07-26 | Inhibiteurs de pompe a protons isotopiquement substitues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200800203A1 EA200800203A1 (ru) | 2008-08-29 |
| EA016814B1 true EA016814B1 (ru) | 2012-07-30 |
Family
ID=35734406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200800203A EA016814B1 (ru) | 2005-07-26 | 2006-07-26 | Замещенные изотопами ингибиторы протонного насоса |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1910293A1 (fr) |
| JP (1) | JP5448448B2 (fr) |
| KR (1) | KR101358509B1 (fr) |
| CN (2) | CN102134232B (fr) |
| AR (1) | AR054584A1 (fr) |
| AU (1) | AU2006274036B2 (fr) |
| BR (1) | BRPI0614039A2 (fr) |
| CA (1) | CA2615670C (fr) |
| EA (1) | EA016814B1 (fr) |
| HK (2) | HK1125098A1 (fr) |
| IL (1) | IL188773A (fr) |
| MX (1) | MX2008000901A (fr) |
| NO (1) | NO20080839L (fr) |
| NZ (1) | NZ565078A (fr) |
| TW (1) | TWI394750B (fr) |
| WO (1) | WO2007012650A1 (fr) |
| ZA (1) | ZA200800303B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR054583A1 (es) * | 2005-07-26 | 2007-06-27 | Altana Pharma Ag | Pantoprazol isotopicamente sustituido |
| WO2007041630A1 (fr) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Inhibiteurs deutériés d'atpase h+,k+ gastrique ayant des propriétés thérapeutiques renforcées |
| US20080255200A1 (en) * | 2007-04-11 | 2008-10-16 | Auspex Pharmaceuticals, Inc. | Substituted benzimidazoles |
| WO2008127640A2 (fr) * | 2007-04-11 | 2008-10-23 | Auspex Pharmaceuticals, Inc. | Benzimidazoles substitués |
| ES2523921T3 (es) | 2010-02-12 | 2014-12-02 | Esteve Química, S.A. | Procedimiento de preparación de la sal sódica de esomeprazol |
| CN104530003A (zh) * | 2014-06-10 | 2015-04-22 | 广东东阳光药业有限公司 | 吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0005129A1 (fr) * | 1978-04-14 | 1979-10-31 | Aktiebolaget Hässle | Pyridylsulfinylbenzimidazoles substitués, compositions pharmaceutiques les renfermant et les intermédiaires pour leur préparation |
| EP0254588A1 (fr) * | 1986-07-25 | 1988-01-27 | Tokyo Tanabe Company Limited | Composés d'imidazo[4,5-b]pyridine, leur procédé de préparation et compositions pharmaceutiques les contenants |
| US6818200B2 (en) * | 1994-03-25 | 2004-11-16 | Isotechnika Inc. | Method of using deuterated calcium channel blockers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995026325A2 (fr) * | 1994-03-25 | 1995-10-05 | Isotechnika Inc. | Potentialisation de medicaments par deuteration_______________ |
| US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
| NO309305B1 (no) * | 1999-02-19 | 2001-01-15 | Norsk Hydro As | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
| DE10123129A1 (de) * | 2001-05-02 | 2002-11-14 | Berolina Drug Dev Ab Svedala | Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel |
| DE10162121A1 (de) * | 2001-12-12 | 2003-06-18 | Berolina Drug Dev Ab Svedala | Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel |
| AR054583A1 (es) * | 2005-07-26 | 2007-06-27 | Altana Pharma Ag | Pantoprazol isotopicamente sustituido |
-
2006
- 2006-07-26 CN CN2011100224850A patent/CN102134232B/zh not_active Expired - Fee Related
- 2006-07-26 KR KR1020087003989A patent/KR101358509B1/ko not_active IP Right Cessation
- 2006-07-26 CN CN2006800345034A patent/CN101268051B/zh not_active Expired - Fee Related
- 2006-07-26 AR ARP060103224A patent/AR054584A1/es unknown
- 2006-07-26 EP EP06764258A patent/EP1910293A1/fr not_active Withdrawn
- 2006-07-26 WO PCT/EP2006/064666 patent/WO2007012650A1/fr active Application Filing
- 2006-07-26 CA CA2615670A patent/CA2615670C/fr not_active Expired - Fee Related
- 2006-07-26 TW TW095127340A patent/TWI394750B/zh not_active IP Right Cessation
- 2006-07-26 BR BRPI0614039-4A patent/BRPI0614039A2/pt not_active IP Right Cessation
- 2006-07-26 MX MX2008000901A patent/MX2008000901A/es active IP Right Grant
- 2006-07-26 AU AU2006274036A patent/AU2006274036B2/en not_active Ceased
- 2006-07-26 NZ NZ565078A patent/NZ565078A/en not_active IP Right Cessation
- 2006-07-26 JP JP2008523354A patent/JP5448448B2/ja not_active Expired - Fee Related
- 2006-07-26 EA EA200800203A patent/EA016814B1/ru not_active IP Right Cessation
-
2008
- 2008-01-10 ZA ZA2008/00303A patent/ZA200800303B/en unknown
- 2008-01-15 IL IL188773A patent/IL188773A/en not_active IP Right Cessation
- 2008-02-18 NO NO20080839A patent/NO20080839L/no not_active Application Discontinuation
-
2009
- 2009-03-12 HK HK09102398.5A patent/HK1125098A1/xx not_active IP Right Cessation
-
2012
- 2012-01-18 HK HK12100603.5A patent/HK1160126A1/xx not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0005129A1 (fr) * | 1978-04-14 | 1979-10-31 | Aktiebolaget Hässle | Pyridylsulfinylbenzimidazoles substitués, compositions pharmaceutiques les renfermant et les intermédiaires pour leur préparation |
| EP0254588A1 (fr) * | 1986-07-25 | 1988-01-27 | Tokyo Tanabe Company Limited | Composés d'imidazo[4,5-b]pyridine, leur procédé de préparation et compositions pharmaceutiques les contenants |
| US6818200B2 (en) * | 1994-03-25 | 2004-11-16 | Isotechnika Inc. | Method of using deuterated calcium channel blockers |
Non-Patent Citations (1)
| Title |
|---|
| ARNE BR?äNDSTR?ûM ET AL.: "Chemical reactions of omeprazole and omeprazole analogues VI. The reactions of omeprazole in the absence of 2-mercaptoethanol", ACTA CHEMICA SCANDINAVICA, no. 43, 1989, pages 595-611, XP009061378, page 610, right-hand column, last paragraph - page 611, left-hand column, paragraph 1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2615670A1 (fr) | 2007-02-01 |
| TW200714596A (en) | 2007-04-16 |
| AR054584A1 (es) | 2007-06-27 |
| EA200800203A1 (ru) | 2008-08-29 |
| KR101358509B1 (ko) | 2014-02-05 |
| NO20080839L (no) | 2008-02-18 |
| EP1910293A1 (fr) | 2008-04-16 |
| CN101268051A (zh) | 2008-09-17 |
| CN101268051B (zh) | 2011-08-31 |
| CN102134232A (zh) | 2011-07-27 |
| IL188773A (en) | 2014-02-27 |
| ZA200800303B (en) | 2009-01-28 |
| JP2009502871A (ja) | 2009-01-29 |
| MX2008000901A (es) | 2008-03-26 |
| BRPI0614039A2 (pt) | 2011-03-09 |
| NZ565078A (en) | 2010-03-26 |
| AU2006274036A2 (en) | 2008-03-20 |
| CN102134232B (zh) | 2012-11-21 |
| JP5448448B2 (ja) | 2014-03-19 |
| TWI394750B (zh) | 2013-05-01 |
| AU2006274036B2 (en) | 2012-05-24 |
| CA2615670C (fr) | 2015-01-20 |
| AU2006274036A1 (en) | 2007-02-01 |
| HK1125098A1 (en) | 2009-07-31 |
| WO2007012650A1 (fr) | 2007-02-01 |
| HK1160126A1 (en) | 2012-08-10 |
| KR20080037676A (ko) | 2008-04-30 |
| IL188773A0 (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5289951B2 (ja) | 同位体置換されたパントプラゾール | |
| CA2735162C (fr) | Composes pyrrole | |
| EP0654471B1 (fr) | Dérivés de pyridine, compositions pharmaceutiques les contenant, leur utilisation pour le préparation de médicaments de valeur thérapeutique ou préventive et procédé pour leur préparation | |
| NO841754L (no) | Fremgangsmaate ved fremstilling av nye fluoralkoksyforbindelser | |
| JP2003534232A (ja) | プロトン・ポンプ・インヒビターのプロドラッグ | |
| EP1861391B1 (fr) | Méthodes de synthèse des dérivés de sulfoxyde substitués | |
| EA016814B1 (ru) | Замещенные изотопами ингибиторы протонного насоса | |
| JPH10501254A (ja) | 置換アリールアルキルチオアルキルチオピリジン | |
| JPH05117268A (ja) | ピリジン化合物 | |
| JP2002510293A (ja) | 抗潰瘍剤として新規なベンゾイミダゾール誘導体、それらの製造方法、及びそれらを含有する薬学的組成物 | |
| US7601737B2 (en) | Isotopically substituted proton pump inhibitors | |
| WO2021104256A1 (fr) | Dérivé hétérocylique, composition pharmaceutique et utilisation associées | |
| JP2007534723A (ja) | ジアルコキシ−イミダゾピリジン誘導体 | |
| JP2004529969A (ja) | 新規のピリジルメチルアミノピリミジン | |
| JP2008502654A (ja) | プロトンポンプインヒビターとしてのアミノ−ハロゲン−イミダゾピリジン | |
| AU2002314064A1 (en) | Novel pyridylmethylaminopyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |